SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-020462
Filing Date
2019-05-24
Accepted
2019-05-24 16:00:38
Documents
4
Period of Report
2019-07-10
Effectiveness Date
2019-05-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A sbph-def14a_20190710.htm DEF 14A 810422
2 GRAPHIC geksvzxfcppd000003.jpg GRAPHIC 1901
3 GRAPHIC geksvzxfcppd000001.jpg GRAPHIC 6279
4 GRAPHIC geksvzxfcppd000002.jpg GRAPHIC 1565
  Complete submission text file 0001564590-19-020462.txt   825384
Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37718 | Film No.: 19854374
SIC: 2834 Pharmaceutical Preparations